Research programme: herpes simplex virus-2 vaccines - BlueWillow Biologics

Drug Profile

Research programme: herpes simplex virus-2 vaccines - BlueWillow Biologics

Alternative Names: Nanoemulsion adjuvanted intramuscular HSV-2 vaccine - BlueWillow Biologics; Nanoemulsion adjuvanted intranasal HSV-2 vaccine - BlueWillow Biologics; NE glycoprotein vaccine - BlueWillow Biologics; NE-HSV2

Latest Information Update: 09 May 2018

Price : *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator NanoBio Corporation
  • Developer BlueWillow Biologics
  • Class Viral vaccines
  • Mechanism of Action Immunostimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Preclinical Herpes simplex virus type 2 infections

Most Recent Events

  • 07 May 2018 NanoBio Corporation is now called BlueWillow Biologics
  • 06 Mar 2017 Research programme: herpes simplex virus-2 vaccines is still in preclinical development for Herpes simplex virus type-2 infections (prevention and treatment) (Intranasal, IM) in USA
  • 06 Mar 2017 NanoBio Corporation receives a phase II SBIR grant from National Institute of Allergy and Infectious Diseases (NIAID) for Herpes simplex virus-2 infection (Prevention) (Intranasal)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top